Journal of Lipid Research, Vol 35, 478-483, Copyright © 1994 by Lipid Research, Inc.

ARTICLES

Molecular genetics of cerebrotendinous xanthomatosis in Jews of north African origin

A Reshef, V Meiner, VM Berginer and E Leitersdorf
Division of Medicine, Hadassah University Hospital, Jerusalem, Israel.

Cerebrotendinous xanthomatosis (CTX) is an autosomal recessive sterol storage disease characterized by the accumulation of a bile alcohol, cholestanol, in diverse tissues. The disorder is manifested by extensive nervous system involvement, juvenile cataracts, tendon xanthomas, and premature atherosclerosis and is caused by sterol 27- hydroxylase (EC 1.14.13.15) mutations. Recently, two mutations were shown to cause CTX in four Jewish families of Moroccan origin. An additional mutant allele, found in a Jewish family of Algerian origin is characterized here. Sequence analysis revealed a C to T transition at cDNA position 1037 which predicted a threonine to methionine substitution at residue 306 (designated T306M). It is highly suggestive, but not definitive, that this transition is the mutation causing CTX in this family. A search for additional cases from Jewish families of North African extraction identified five new families including 10 cases. The three sterol 27-hydroxylase gene mutations account for all 10 CTX families and their presence may suggest the existence of positive selective forces that lead to an increased prevalence of this relatively rare disease in Jews from North Africa.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M.-H. Lee, S. Hazard, J. D. Carpten, S. Yi, J. Cohen, G. T. Gerhardt, G. Salen, and S. B. Patel Fine-mapping, mutation analyses, and structural mapping of cerebrotendinous xanthomatosis in U.S. pedigrees J. Lipid Res., February 1, 2001; 42(2): 159 - 169. [Abstract] [Full Text]

				A. Verrips, L. H. Hoefsloot, G. C. H. Steenbergen, J. P. Theelen, R. A. Wevers, F. J. M. Gabreels, B. G. M. van Engelen, and L. P. W. J. van den Heuvel Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis Brain, May 1, 2000; 123(5): 908 - 919. [Abstract] [Full Text] [PDF]

				A. Verrips, B. G. M. van Engelen, R. A. Wevers, B. M. van Geel, J. R. M. Cruysberg, L. P. W. J. van den Heuvel, A. Keyser, and F. J. M. Gabreels Presence of Diarrhea and Absence of Tendon Xanthomas in Patients With Cerebrotendinous Xanthomatosis Arch Neurol, April 1, 2000; 57(4): 520 - 524. [Abstract] [Full Text] [PDF]

				N. Wakamatsu, M. Hayashi, H. Kawai, H. Kondo, Y. Gotoda, Y. Nishida, R. Kondo, S. Tsuji, and T. Matsumoto Mutations producing premature termination of translation and an amino acid substitution in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis associated with parkinsonism J. Neurol. Neurosurg. Psychiatry, August 1, 1999; 67(2): 195 - 198. [Abstract] [Full Text] [PDF]

				A. Verrips, G. J. Lycklama a Nijeholt, F. Barkhof, B. G. M. Van Engelen, P. Wesseling, J. A. F. M. Luyten, R. A. Wevers, J. Stam, J. H. J. Wokke, L. P. W. J. van den Heuvel, et al. Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis Brain, August 1, 1999; 122(8): 1589 - 1595. [Abstract] [Full Text] [PDF]

				H. Rosen, A. Reshef, N. Maeda, A. Lippoldt, S. Shpizen, L. Triger, G. Eggertsen, I. Bjorkhem, and E. Leitersdorf Markedly Reduced Bile Acid Synthesis but Maintained Levels of Cholesterol and Vitamin D Metabolites in Mice with Disrupted Sterol 27-Hydroxylase Gene J. Biol. Chem., June 12, 1998; 273(24): 14805 - 14812. [Abstract] [Full Text] [PDF]

				W. Chen, S. Kubota, and Y. Seyama Alternative pre-mRNA splicing of the sterol 27-hydroxylase gene (CYP 27) caused by a G to A mutation at the last nucleotide of exon 6 in a patient with cerebrotendinous xanthomatosis (CTX) J. Lipid Res., March 1, 1998; 39(3): 509 - 517. [Abstract] [Full Text]